Aconitase 1/ACO1 Antibody (Rabbit mAb) [K17A22]

Catalog No.: F8312

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000 - 1:20000
    Application
    WB
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    98 kDa

    Datasheet & SDS

    生物学的記述

    Specificity
    Aconitase 1/ACO1 Antibody (Rabbit mAb) [K17A22] detects endogenous levels of total Aconitase 1/ACO1 protein.
    Clone
    K17A22
    Synonym(s)
    IREB1, ACO1, Cytoplasmic aconitate hydratase, Aconitase, Citrate hydro-lyase, Ferritin repressor protein, Iron regulatory protein 1, Iron-responsive element-binding protein 1, IRP1, IRE-BP 1
    Background
    Aconitase 1 (ACO1), also known as cytosolic aconitase or iron regulatory protein 1 (IRP1), is a bifunctional member of the aconitase family that links intermediary metabolism with iron homeostasis by switching between an enzymatic aconitase state and an RNA‑binding regulatory state depending on the status of its iron–sulfur cluster. The protein contains a [4Fe–4S] cluster embedded in a multi‑domain scaffold that positions one iron atom in a solvent‑exposed pocket, allowing direct interaction of the cluster with citrate and cis‑aconitate during catalysis and creating the structural basis for its sensitivity to iron availability and oxidative modifications. In its holo form carrying an intact [4Fe–4S] cluster, ACO1 catalyzes the reversible isomerization of citrate to isocitrate via cis‑aconitate, integrating into the cytosolic extension of the tricarboxylic acid cycle and influencing citrate–isocitrate flux that supports NADPH generation and acetyl‑CoA supply for biosynthetic pathways. Loss or disassembly of the iron–sulfur cluster converts ACO1 into an apo form that undergoes conformational rearrangement to expose RNA‑binding surfaces, enabling high‑affinity recognition of iron‑responsive elements (IREs) in the untranslated regions of mRNAs encoding ferritin, transferrin receptor and other iron‑handling proteins. Binding of IRP1/ACO1 to IREs in ferritin mRNA represses its translation, while interaction with IREs in transferrin receptor mRNA stabilizes the transcript and supports continued receptor synthesis, establishing a post‑transcriptional regulatory circuit that adjusts iron storage and uptake according to intracellular iron levels. Changes in iron availability and in Fe–S cluster biogenesis alter the balance between the aconitase and IRE‑binding states, so that iron sufficiency favors the catalytic aconitase conformation and directs citrate flux, whereas iron depletion or disruption of Fe–S assembly promotes the RNA‑binding form and enhances control over iron transport and storage gene expression. Reactive oxygen and nitrogen species, including superoxide and hydrogen peroxide, oxidize the Fe–S cluster and trigger its disassembly, which reduces aconitase catalytic activity and increases IRP1‑type regulatory behavior, indicating that ACO1 also functions as a sensor of redox and inflammatory conditions that intersect with iron metabolism. In adipose tissue, modulation of ACO1 expression and activity affects adipogenic capacity by altering isocitrate dehydrogenase expression, NADPH/NADP ratios and transferrin receptor levels, tying its metabolic and iron‑regulatory actions to the maintenance of adipose energy metabolism and iron uptake. At the pathway level, ACO1 occupies a nodal position between the citric acid cycle, iron transport and storage systems, and oxidative stress responses, and its structural capacity to undergo an Fe–S‑dependent conformational transition provides a mechanistic framework for studying how cells coordinate ATP production, biosynthetic demand and iron handling in physiological and disease contexts.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください